Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Sahm

Showing results (131-140 of 450) with videos related to

Pageof 45
Sort By:
International Journal of Molecular Sciences|January 12, 2021
Fibulin-2: A Novel Biomarker for Differentiating Grade II from Grade I MeningiomasAgbolahan A Sofela, David A Hilton, Sylwia Ammoun, et al.
Neurology|July 7, 2017
Sural nerve injury in familial amyloid polyneuropathy: MR neurography vs clinicopathologic toolsJennifer Kollmer, Felix Sahm, Ute Hegenbart, et al.
Journal of Neuropathology and Experimental Neurology|November 21, 2025
Analysis of anatomical location, mitoses, and Ki-67 in 2608 meningiomasAnders Broechner, Andrea Daniela Maier, Christian Mirian, et al.
Neuro-Oncology|February 16, 2021
Integrated molecular analysis of adult sonic hedgehog (SHH)-activated medulloblastomas reveals two clinically relevant tumor subsets with VEGFA as potent prognostic indicatorAndrey Korshunov, Konstantin Okonechnikov, Damian Stichel, et al.
Nature Biomedical Engineering|July 28, 2025
Integrated in vivo combinatorial functional genomics and spatial transcriptomics of tumours to decode genotype-to-phenotype relationshipsMarco Breinig, Artem Lomakin, Elyas Heidari, et al.
Frontiers in Oncology|September 10, 2025
Radiomics features from the peritumoral region can be associated with the epilepsy status of glioblastoma patientsYeong Chul Yun, Johann M E Jende, Katharina Holz, et al.
Acta Neuropathologica|August 22, 2014
Farewell to oligoastrocytoma: in situ molecular genetics favor classification as either oligodendroglioma or astrocytomaFelix Sahm, David Reuss, Christian Koelsche, et al.
Neuroimage. Clinical|October 1, 2020
Ultra-high-field sodium MRI as biomarker for tumor extent, grade and IDH mutation status in glioma patientsSebastian Regnery, Nicolas G R Behl, Tanja Platt, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 19, 2025
Expression of SSTR2a, FAP, HER2 and HER3 as potential radionuclide therapy targets in higher-grade meningiomaMaximilian J Mair, Sabrina Hartenbach, Erwin Tomasich, et al.
Journal of Neuro-Oncology|April 17, 2025
Combined peritumoral radiomics and clinical features predict 12-month progression free survival in glioblastomaYeong Chul Yun, Johann M E Jende, Freya Garhöfer, et al.
Pageof 45

Showing results (131-140 of 450) with videos related to

Sort By:
Pageof 45
International Journal of Molecular Sciences|January 12, 2021
Fibulin-2: A Novel Biomarker for Differentiating Grade II from Grade I MeningiomasAgbolahan A Sofela, David A Hilton, Sylwia Ammoun, et al.
Neurology|July 7, 2017
Sural nerve injury in familial amyloid polyneuropathy: MR neurography vs clinicopathologic toolsJennifer Kollmer, Felix Sahm, Ute Hegenbart, et al.
Journal of Neuropathology and Experimental Neurology|November 21, 2025
Analysis of anatomical location, mitoses, and Ki-67 in 2608 meningiomasAnders Broechner, Andrea Daniela Maier, Christian Mirian, et al.
Neuro-Oncology|February 16, 2021
Integrated molecular analysis of adult sonic hedgehog (SHH)-activated medulloblastomas reveals two clinically relevant tumor subsets with VEGFA as potent prognostic indicatorAndrey Korshunov, Konstantin Okonechnikov, Damian Stichel, et al.
Nature Biomedical Engineering|July 28, 2025
Integrated in vivo combinatorial functional genomics and spatial transcriptomics of tumours to decode genotype-to-phenotype relationshipsMarco Breinig, Artem Lomakin, Elyas Heidari, et al.
Frontiers in Oncology|September 10, 2025
Radiomics features from the peritumoral region can be associated with the epilepsy status of glioblastoma patientsYeong Chul Yun, Johann M E Jende, Katharina Holz, et al.
Acta Neuropathologica|August 22, 2014
Farewell to oligoastrocytoma: in situ molecular genetics favor classification as either oligodendroglioma or astrocytomaFelix Sahm, David Reuss, Christian Koelsche, et al.
Neuroimage. Clinical|October 1, 2020
Ultra-high-field sodium MRI as biomarker for tumor extent, grade and IDH mutation status in glioma patientsSebastian Regnery, Nicolas G R Behl, Tanja Platt, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 19, 2025
Expression of SSTR2a, FAP, HER2 and HER3 as potential radionuclide therapy targets in higher-grade meningiomaMaximilian J Mair, Sabrina Hartenbach, Erwin Tomasich, et al.
Journal of Neuro-Oncology|April 17, 2025
Combined peritumoral radiomics and clinical features predict 12-month progression free survival in glioblastomaYeong Chul Yun, Johann M E Jende, Freya Garhöfer, et al.
Pageof 45